Metraipolis › archive › dc_d74b63f7fc54

A patient-centered 'test-drive' strategy for ankle-foot orthosis prescription: Protocol for a randomized participant-blinded trial — Europe PMC PMID:38696428

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38696428
DOI
10.1371/journal.pone.0302389
License (as archived)
CC0-1.0
Archived
2026-10-06T18:46:39.185Z
SHA-256 of the archived text
f8720479a699edabb5d70498055da0b502d7fad9da94d62d9af6269ef64976ad
Stable URL of this page
https://metraipolis.com/documento/dc_d74b63f7fc54

How to cite

A patient-centered 'test-drive' strategy for ankle-foot orthosis prescription: Protocol for a randomized participant-blinded trial — Europe PMC PMID:38696428 — Europe PMC (en), https://europepmc.org/article/MED/38696428 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d74b63f7fc54 (Metraipolis archive dc_d74b63f7fc54, sha256 f8720479a699edabb5d70498055da0b502d7fad9da94d62d9af6269ef64976ad)
BibTeX
@misc{dcd74b63f7fc54,
  title = {A patient-centered 'test-drive' strategy for ankle-foot orthosis prescription: Protocol for a randomized participant-blinded trial — Europe PMC PMID:38696428},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38696428},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d74b63f7fc54; sha256 f8720479a699edabb5d70498055da0b502d7fad9da94d62d9af6269ef64976ad},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38696428. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Ankle-foot orthoses (AFOs) are commonly used to overcome mobility limitations related to lower limb musculoskeletal injury. Despite a multitude of AFOs to choose from, there is scant evidence to guide AFO prescription and limited opportunities for AFO users to provide experiential input during the process. To address these limitations in the current prescription process, this study evaluates a novel, user-centered and personalized 'test-drive' strategy using a robotic exoskeleton ('AFO emulator') to emulate commercial AFO mechanical properties (i.e., stiffness). The study will determine if brief, in-lab trials (with emulated or actual AFOs) can predict longer term preference, satisfaction, and mobility outcomes after community trials (with the actual AFOs). Secondarily, it will compare the in-lab experience of walking between actual vs. emulated AFOs. Methods and analysis: In this participant-blinded, randomized crossover study we will recruit up to fifty-eight individuals with lower limb musculoskeletal injuries who currently use an AFO. Participants will walk on a treadmill with three actual AFOs and corresponding emulated AFOs for the "in-lab" assessments. For the community trial assessment, participants will wear each of the actual AFOs for a two-week period during activities of daily living. Performance-based and user-reported measures of preference and mobility will be compared between short- and long-term trials (i.e., in-lab vs. two-week community trials), and between in-lab trials (emulated vs. actual AFOs). Trial registration: The study was prospectively registered at www.clininicaltrials.gov (Clinical Trials Study ID: NCT06113159). Date: November 1st 2023. https://classic.clinicaltrials.gov/ct2/show/NCT06113159.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-05-02).
Identificativi: PMID 38696428 · PMCID PMC11065291 · DOI 10.1371/journal.pone.0302389.
Descrittori MeSH principali: Foot Orthoses.
Pagina: https://europepmc.org/article/MED/38696428 — https://doi.org/10.1371/journal.pone.0302389. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T17:12:53.191Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.